Kura Oncology News and Activities

Presence

Kura Oncology develops cancer medicines for targeted treatment. Its main services include drug discovery, clinical development, and oncology therapy programs for hospitals, cancer specialists, and patients with serious blood and solid tumor diseases.

Kura Oncology products and services overview:

Targeted oncology
Cancer therapies
Small molecule drugs
Clinical development
Drug discovery

Revenue: ~$73 million

Employees: 210

Headquarters: San Diego, United States (USA)

Kura Oncology is one of the...

Kura Oncology is a company listed under the stock ticker KURA (US).

Executives

View the org chart displaying its 29 main executives

Most searched biographies at Kura Oncology

Popular executive movements at Kura Oncology

Arlette Holland, Senior Director, Clinical Trial Management Operational Excellence, has left the company (posted on April 22 2026).
Laura Cooper has joined the company as Senior Director, Corporate Communications (posted on December 12 2025).

Create your alert
to follow the executive moves at Kura Oncology.